New Investigative Therapy for Methylmalonic Acidemia and Propionic Acidemia is Making Regulatory Progress
source: pixabay.com

New Investigative Therapy for Methylmalonic Acidemia and Propionic Acidemia is Making Regulatory Progress

Fast Track Designation and Rare Pediatric Disease Designation have just been awarded from the FDA to HemoShear Therapeutics. This designation was given to their new investigative therapy for propionic acidemia…

Continue Reading New Investigative Therapy for Methylmalonic Acidemia and Propionic Acidemia is Making Regulatory Progress